Back
0001104659-20-095150
Avoro Capital Advisors LLC
Total Value: $5,058,020,000
Total Holdings: 45
QuarterFilling ID
Q4 250002002654-26-000001
Q3 250002002654-25-000006
Q2 250002002654-25-000004
Q1 250002002654-25-000003
Q4 240002002654-25-000001
Q3 240002002654-24-000005
Q2 240002002654-24-000004
Q1 240002002654-24-000002
Q4 230002002654-24-000001
Q3 230002002654-23-000008
Q2 230002002654-23-000007
Q1 230002002654-23-000006
Q4 220002002654-23-000005
Q3 220002002654-23-000004
Q2 220002002654-23-000003
Q1 220002002654-23-000002
Q4 210002002654-23-000001
Compare Quarter:
NameTitleCUSIPTickerValueSharesShare PriceInvestment% of Portfolio
IMMUNOMEDICS INCCommon452907108$930,30026,250,000SOLE
MIRATI THERAPEUTICS INCCommon60468T105$489,4204,286,765SOLE
HORIZON THERAPEUTICS PLCCommonG46188101$333,4806,000,000SOLE
IOVANCE BIOTHERAPEUTICS INCCommon462260100$284,41110,361,039SOLE
SAREPTA THERAPEUTICS INCCommon803607100$268,5701,675,000SOLE
ASCENDIS PHARMASponsored ADR04351P101$258,8251,750,000SOLE
BIOMARIN PHARMACEUTICAL INCCommon09061G101$228,1791,850,000SOLE
ARGENX SESponsored ADR04016X101$218,473970,000SOLE
MYOKARDIA INCCommon62857M105$181,6461,880,000SOLE
AMICUS THERAPEUTICS INCCommon03152W109$165,88011,000,000SOLE
ADVERUM BIOTECHNOLOGIES INCCommon00773U108$158,3757,585,000SOLE
MERSANA THERAPEUTICS INCCommon59045L106$152,1006,500,000SOLE
KARYOPHARM THERAPEUTICS INCCommon48576U106$132,5807,000,000SOLE
CONSTELLATION PHARMACEUTICALS INCCommon210373106$120,2004,000,000SOLE
DECIPHERA PHARMACEUTICALS INCCommon24344T101$111,0791,860,000SOLE
ADAPTIMMUNE THERAPEUTICS PLCSponsored ADR00653A107$100,17010,200,000SOLE
ACCELERON PHARMA INCCommon00434H108$99,0811,040,000SOLE
UNIQURE NVCommonN90064101$67,5901,500,000SOLE
RELMADA THERAPEUTICS INCCommon75955J402$63,7691,425,000SOLE
ZOGENIX INCCommon98978L204$60,7732,250,000SOLE
ARENA PHARMACEUTICALS INCCommon40047607$59,803950,000SOLE
ATHENEX INCCommon04685N103$52,9763,850,000SOLE
ALLOGENE THERAPEUTICS INCCommon19770106$48,3261,128,594SOLE
CUE BIOPHARMA INCCommon22978P106$45,8341,870,000SOLE
MADRIGAL PHARMACEUTICALS INCCommon558868105$39,638350,000SOLE
TRILLIUM THERAPEUTICS INCCommon89620X506$38,4284,750,000SOLE
AVADEL PHARMACEUTICALS PLCSponsored ADR05337M104$36,8904,565,655SOLE
IVERIC BIO INCCommon46583P102$36,2107,100,000SOLE
XENON PHARMACEUTICALS INCCommon98420N105$35,1122,800,000SOLE
MARINUS PHARMACEUTICALS INCCommon56854Q101$30,37811,960,000SOLE
AURINIA PHARMACEUTICALS INCCommon05156V102$27,1381,670,000SOLE
BLACK DIAMOND THERAPEUTICS INCCommon09203E105$22,134525,000SOLE
RETROPHIN INCCommon761299106$21,4311,050,000SOLE
CYMABAY THERAPEUTICS INCCommon23257D103$18,3235,250,000SOLE
KURA ONCOLOGY INCCommon50127T109$17,1151,050,000SOLE
AVIDITY BIOSCIENCES INCCommon05370A108$16,532585,000SOLE
TRICIDA INCCommon89610F101$16,488600,000SOLE
PTC THERAPEUTICS INCCommon69366J200$16,478324,750SOLE
FENNEC PHARMACEUTICALS INCCommon31447P100$13,9451,670,000SOLE
AMARIN CORP PLCSponsored ADR23111206$13,8402,000,000SOLE
REVOLUTION MEDICINES INCCommon76155X100$9,597304,000SOLE
BIODELIVERY SCIENCES INTLCommon09060J106$8,8722,034,900SOLE
CARDIFF ONCOLOGY INCCommon14147L108$5,0101,000,000SOLE
ALIMERA SCIENCES INCCommon16259202$2,621415,999SOLE
© 2026 13F • Hedge Fund Alpha